Myeloma Update From ASCO 2017


On location at the recent 2017 American Society of Clinical Oncology meeting (ASCO), Dr. Hearn Jay Cho of Mount Sinai Hospital discusses news out of ASCO 2017 and what it means for myeloma patients and care partners. Dr. Cho highlights news out of the meeting, including how experts are manipulating the immune system, precision medicine efforts in myeloma targeting specific mutations and adoptive therapies in myeloma. 

Sign in or Register to view comments.